299
Views
6
CrossRef citations to date
0
Altmetric
Glaucoma

Factors Associated with Loss of Visual Function in Medically Treated Advanced Normal Tension Glaucoma

&
Pages 429-435 | Received 17 Feb 2016, Accepted 26 May 2016, Published online: 15 Jul 2016

References

  • The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol 2000;130:429–440.
  • Caprioli J, Spaeth GL. Comparison of visual field defects in the low-tension glaucomas with those in the high-tension glaucomas. Am J Ophthalmol 1984;97:730–737.
  • Araie M. Pattern of visual field defects in normal-tension and high-tension glaucoma. Curr Opin Ophthalmol 1995;6:36–45.
  • Sung KR, Cho JW, Lee S, Yun SC, Choi J, Na JH, et al. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure. Invest Ophthalmol Vis Sci 2011;52:737–43.
  • Anderson DR. Collaborative normal tension glaucoma study. Curr Opin Ophthalmol 2003;14:86–90.
  • Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003;121:48–56.
  • Anderson DR. Automated Static Perimetry. Mosby 1992:91–137.
  • Heijl A, Bengtsson B, Hyman L, Leske MC. Natural history of open-angle glaucoma. Ophthalmology 2009;116:2271–2276.
  • Kim CS, Seong GJ, Lee NH, Song KC. Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology 2011;118:1024–1030.
  • Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 2004;111:1641–1648.
  • Wilson R, Walker AM, Dueker DK, Crick RP. Risk factors for rate of progression of glaucomatous visual field loss: a computer-based analysis. Arch Ophthalmol 1982;100:737–741.
  • Gardiner SK, Swanson WH, Goren D, Mansberger SL, Demirel S. Assessment of the reliability of standard automated perimetry in regions of glaucomatous damage. Ophthalmology 2014;121:1359–1369.
  • The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol 2002;134:499–512.
  • Lichter PR, Musch DC, Gillespie BW, Gillespie BW, Guire KE, Janz NK, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108:1943–1953.
  • Suzuki Y, Iwase A, Araie M, Yamamoto T, Abe H, Shirato S, et al. Risk Factors for Open-Angle Glaucoma in a Japanese Population: The Tajimi Study. Ophthalmology 2006;113:1613–1617.
  • Kim YJ, Yun SC, Na JH, Tchah HW, Jung JJ, Sung KR. Glaucoma progression in eyes with a history of refractive corneal surgery. Invest Ophthalmol Vis Sci 2012;53:4485–4489.
  • Sohn SW, Song JS, Kee C. Influence of the extent of myopia on the progression of normal-tension glaucoma. Am J Ophthalmol 2010;149:831–838.
  • Chihara E, Liu X, Dong J, Takashima Y, Akimoto M, Hangai M, et al. Severe myopia as a risk factor for progressive visual field loss in primary open-angle glaucoma. Ophthalmologica 1997;211:66–71.
  • Kimura Y, Hangai M, Morooka S, Takayama K, Nakano N, Nukada M, et al. Retinal nerve fiber layer defects in highly myopic eyes with early glaucoma. Invest Ophthalmol Vis Sci 2012;53:6472–6478.
  • Sung KR, Lee S, Park SB, Choi J, Kim ST, Yun SC, et al. Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression. Invest Ophthalmol Vis Sci 2009;50:5266–5274.
  • Doshi A, Kreidl KO, Lombardi L, Sakamoto DK, Singh K. Nonprogressive glaucomatous cupping and visual field abnormalities in young Chinese males. Ophthalmology 2007;114:472–479.
  • Chang RT, Singh K. Myopia and glaucoma: diagnostic and therapeutic challenges. Curr Opin Ophthalmol 2013;24:96–101.
  • Lee JY, Sung KR, Han S, Na JH. Effect of myopia on the progression of primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2015;56:1775–1781.
  • Lee JE, Sung KR, Lee JY, Park JM. Implications of optic disc tilt in the progression of primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2015;56:6925–6931.
  • Lee JY, Sung KR, Yun SC. Comparison of rates of retinal nerve fibre layer thinning between patients with non-myopic and myopic glaucoma. Br J Ophthalmol 2015 Aug 28. pii: bjophthalmol-2015-307343.
  • Choi YJ, Kim M, Park KH, Kim DM, Kim SH. The risk of newly developed visual impairment in treated normal-tension glaucoma: 10-year follow-up. Acta Ophthalmol.2014;92:644–649.
  • Kim M, Kim DM, Park KH, Kim TW, Jeoung JW, Kim SH. Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up study. Acta Ophthalmol 2013;91:270–275.
  • Kim S, Sung KR, Lee JR, Lee KS. Evaluation of lamina cribrosa in pseudoexfoliation syndrome using spectral-domain optical coherence tomography enhanced depth imaging. Ophthalmology 2013;120:1798–17803.
  • Ren R, Jonas JB, Tian G, Zhen Y, Ma K, Li S, et al. Cerebrospinal fluid pressure in glaucoma: a prospective study. Ophthalmology 2010;117:259–266.
  • Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998;126:498–505.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.